Germline loss-of-function mutations in mTOR pathway gene FLCN in Birt-Hogg-Dubé syndrome predispose not only to chRCC and RO, but also to more aggressive clear cell and papillary RCCs [18]. This evidence concerns the gene FLCN and Birt-Hogg-Dube syndrome.